Cargando…

Design of Liposomal Lidocaine/Cannabidiol Fixed Combinations for Local Neuropathic Pain Treatment

The administration of drug fixed combinations by nanocarriers is a new attractive approach since it can allow improvements in both the skin penetration of cargo compounds and their synergistic effects. The cutaneous administration of lidocaine (LD) and cannabidiol (CBD) combination can be useful for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franzè, Silvia, Angelo, Liliana, Casiraghi, Antonella, Minghetti, Paola, Cilurzo, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504077/ https://www.ncbi.nlm.nih.gov/pubmed/36145663 http://dx.doi.org/10.3390/pharmaceutics14091915

Ejemplares similares

Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
por: Franzé, Silvia, et al.
Publicado: (2018)

Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance
por: Musazzi, Umberto M., et al.
Publicado: (2018)

Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
por: Casiraghi, Antonella, et al.
Publicado: (2020)

Spotlight on Calcipotriol/Betamethasone Fixed-Dose Combination in Topical Formulations: Is There Still Room for Innovation?
por: Selmin, Francesca, et al.
Publicado: (2022)

Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data
por: Franzè, Silvia, et al.
Publicado: (2020)

Regenerated keratin membrane to match the in vitro drug diffusion through human epidermis
por: Selmin, Francesca, et al.
Publicado: (2012)

Lidocaine 5% Patch in Localized Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Design and development of topical liposomal formulations in a regulatory perspective
por: Schlich, Michele, et al.
Publicado: (2021)

Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
por: Likar, Rudolf, et al.
Publicado: (2012)

Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
por: Correa-Illanes, Gerardo, et al.
Publicado: (2010)

Local hyperexcitability of C-nociceptors may predict responsiveness to topical lidocaine in neuropathic pain
por: Landmann, Gunther, et al.
Publicado: (2022)

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
por: Hans, Guy, et al.
Publicado: (2010)

The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence
por: de León-Casasola, Oscar A, et al.
Publicado: (2016)

5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain
por: Casale, Roberto, et al.
Publicado: (2014)

Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case series
por: Likar, Rudolf, et al.
Publicado: (2014)

Effect of Intravenous Lidocaine on the Neuropathic Pain of Failed Back Surgery Syndrome
por: Park, Chan Hong, et al.
Publicado: (2012)

Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability
por: Tam, Emily, et al.
Publicado: (2012)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration
por: Doo, A Ram, et al.
Publicado: (2018)

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
por: Kern, Kai-Uwe, et al.
Publicado: (2013)

Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves
por: Correa-Illanes, Gerardo, et al.
Publicado: (2012)

Insights on cannabidiol's antiallodynic and anxiolytic mechanisms of action in a model of neuropathic pain
por: Schott, Marion
Publicado: (2019)

Combinations of Cannabidiol and Δ(9)-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
por: Sepulveda, Diana E., et al.
Publicado: (2022)

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions
por: Calderón, Enrique, et al.
Publicado: (2016)

Predictive Value of Lidocaine for Treatment Success of Oxcarbazepine in Patients with Neuropathic Pain Syndrome
por: Schipper, Sivan, et al.
Publicado: (2013)

Medicated Foams and Film Forming Dosage Forms as Tools to Improve the Thermodynamic Activity of Drugs to be Administered Through the Skin
por: Gennari, Chiara G.M., et al.
Publicado: (2019)

Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient
por: Rocco, Paolo, et al.
Publicado: (2017)

Caffeic Acid-PLGA Conjugate to Design Protein Drug Delivery Systems Stable to Irradiation
por: Selmin, Francesca, et al.
Publicado: (2015)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain
por: Werdehausen, Robert, et al.
Publicado: (2015)

Intra-Venous Lidocaine to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis
por: Zhu, Bo, et al.
Publicado: (2019)

Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster
por: Casale, Roberto, et al.
Publicado: (2014)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
por: Macêdo-Souza, Carolina, et al.
Publicado: (2023)

Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
por: Nicolaou, Andrew, et al.
Publicado: (2011)

Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content
por: Magri, Giulia, et al.
Publicado: (2019)

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
por: Casey, Sherelle L., et al.
Publicado: (2022)

Peripheral Neuropathic Pain and Pain Related to Complex Regional Pain Syndrome with and without Fixed Dystonia – Efficient Therapeutic Approach with Local Anesthetics
por: Michels, Thomas
Publicado: (2020)

The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use
por: Baron, Ralf, et al.
Publicado: (2016)

Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment
por: Tsai, Jui-Hung, et al.
Publicado: (2023)

Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study
por: Lee, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cnobcoi09v5870980pgv2ft0vf